Abstract: An exhaust pipe includes a first end, a second end, and a wall connecting the first end to the second end. The first end has a first opening, and the second end has a second opening that fluidly communicates with the first opening to define a bore. The wall includes an inner curved second and an outer curved section that includes an indentation. The indentation includes a first inwardly extending part and a second inwardly extending part. The second inwardly extending part includes a through hole having an inner opening and an outer opening. The inner opening is located between the outer opening and the second opening. A diameter of the outer opening is less than a diameter of the inner opening. A thickness of the second inwardly extending part is less than the diameter of the outer opening.

Abstract: An exhaust pipe includes a first end, a second end, and a wall connecting the first end to the second end. The first end has a first opening, and the second end has a second opening that fluidly communicates with the first opening to define a bore. The wall includes an inner curved second and an outer curved section that includes an indentation. The indentation includes a first inwardly extending part and a second inwardly extending part. The second inwardly extending part includes a through hole having an inner opening and an outer opening. The inner opening is located between the outer opening and the second opening. A diameter of the outer opening is less than a diameter of the inner opening. A thickness of the second inwardly extending part is less than the diameter of the outer opening.

Abstract: Described herein are compositions and methods for the inhibition of miR-122 activity. The compositions have certain nucleoside modifications that yield potent inhibitors of miR-122 activity. The compounds may comprise conjugates to facilitate delivery to the liver. The compositions may be administered to subjects infected with hepatitis C virus, as a treatment for hepatitis C virus and related conditions.

Abstract: Packoff seals and processes for using same. In some examples, the packoff seal can include a first end cap and a second end cap, a first insert and a second insert, a first deformable element disposed between the first end cap and the first insert, a second deformable element disposed between the second insert and the second end cap, and a third deformable element disposed between the first insert and the second insert. The first end cap, the first deformable element, the first insert, the third deformable element, the second insert, the second deformable element, and the second end cap together can form a body having a bore extending therethrough. The first deformable element, the second deformable element, and the third deformable element can have a compressive strength that is less than a compressive strength of the first and second inserts.

Abstract: Described herein are compositions and methods for the inhibition of miR-122 activity. The compositions have certain nucleoside modifications that yield potent inhibitors of miR-122 activity. The compounds may comprise conjugates to facilitate delivery to the liver. The compositions may be administered to subjects infected with hepatitis C virus, as a treatment for hepatitis C virus and related conditions.

Abstract: A reductant delivery system for an engine system. The engine system includes an engine having an exhaust conduit and a turbocharger with a compressor. The reductant delivery system having an injector, a storage system, a sensor and a controller. The injector is configured to inject a reductant into the exhaust conduit. The storage system stores the reductant and is configured to receive pressurized air from the compressor. The sensor is configured to determine a pressure of the pressurized air in the storage system. The controller is in communication with the sensor and is configured to increase a power output of the engine in response to the pressure being below a desired pressure.

Abstract: Cable termination assemblies and processes for making and using same. In some examples, the cable termination assembly can include a lower housing and a rope socket housing can be disposed at least partially within a lower housing bore defined by a lower housing inner surface. At least one rope socket retainer can be disposed at least partially within a rope socket bore defined by an inner surface of the rope socket housing. The rope socket housing and rope socket retainer can be configured to secure the rope socket housing to a first set of armor wires of a cable, extending at least partially through the rope socket bore, while leaving interstitial gaps between individual armor wires of the first set of armor wires. A filler can be disposed between the individual armor wires of the first set of armor wires that at least partially fills the interstitial gaps.

Abstract: Packoff seals and processes for using same. In some examples, the packoff seal can include a first end cap and a second end cap, a first insert and a second insert, a first deformable element disposed between the first end cap and the first insert, a second deformable element disposed between the second insert and the second end cap, and a third deformable element disposed between the first insert and the second insert. The first end cap, the first deformable element, the first insert, the third deformable element, the second insert, the second deformable element, and the second end cap together can form a body having a bore extending therethrough. The first deformable element, the second deformable element, and the third deformable element can have a compressive strength that is less than a compressive strength of the first and second inserts.

Abstract: Described herein are compositions and methods for the inhibition of miR-122 activity. The compositions have certain nucleoside modifications that yield potent inhibitors of miR-122 activity. The compounds may comprise conjugates to facilitate delivery to the liver. The compositions may be administered to subjects infected with hepatitis C virus, as a treatment for hepatitis C virus and related conditions.

Abstract: A reductant delivery system for an engine system. The engine system includes an engine having an exhaust conduit and a turbocharger with a compressor. The reductant delivery system having an injector, a storage system, a sensor and a controller. The injector is configured to inject a reductant into the exhaust conduit. The storage system stores the reductant and is configured to receive pressurized air from the compressor. The sensor is configured to determine a pressure of the pressurized air in the storage system. The controller is in communication with the sensor and is configured to increase a power output of the engine in response to the pressure being below a desired pressure.

Abstract: Described herein are compositions and methods for the inhibition of miR-122 activity. The compositions have certain nucleoside modifications that yield potent inhibitors of miR-122 activity. The compounds may comprise conjugates to facilitate delivery to the liver. The compositions may be administered to subjects infected with hepatitis C virus, as a treatment for hepatitis C virus and related conditions.

Abstract: Described herein are compositions and methods for the inhibition of miR-122 activity. The compositions have certain nucleoside modifications that yield potent inhibitors of miR-122 activity. The compounds may comprise conjugates to facilitate delivery to the liver. The compositions may be administered to subjects infected with hepatitis C virus, as a treatment for hepatitis C virus and related conditions.

Abstract: Described herein are compositions and methods for the inhibition of miR-122 activity. The compositions have certain nucleoside modifications that yield potent inhibitors of miR-122 activity. The compounds may comprise conjugates to facilitate delivery to the liver. The compositions may be administered to subjects infected with hepatitis C virus, as a treatment for hepatitis C virus and related conditions.

Abstract: Described herein are compositions and methods for the inhibition of miR-122 activity. The compositions have certain nucleoside modifications that yield potent inhibitors of miR-122 activity. The compounds may comprise conjugates to facilitate delivery to the liver. The compositions may be administered to subjects infected with hepatitis C virus, as a treatment for hepatitis C virus and related conditions.

Abstract: Described herein are compositions and methods for the inhibition of miR-122 activity. The compositions have certain nucleoside modifications that yield potent inhibitors of miR-122 activity. The compounds may comprise conjugates to facilitate delivery to the liver. The compositions may be administered to subjects infected with hepatitis C virus, as a treatment for hepatitis C virus and related conditions.

Abstract: Described herein are compositions and methods for the inhibition of miR-122 activity. The compositions have certain nucleoside modifications that yield potent inhibitors of miR-122 activity. The compounds may comprise conjugates to facilitate delivery to the liver. The compositions may be administered to subjects infected with hepatitis C virus, as a treatment for hepatitis C virus and related conditions.

Abstract: A system for generating web analytic reports includes a client interface unit configured to receive one or more predefined tagging conditions from a client for generating a set of tagging rules based on the one or more predefined tagging conditions. The system also includes a tag generation unit configured to generate a client tagged data based on the set of tagging rules. The system also includes an output interface unit configured to generate web analytic reports via analyzing the client tagged data based on the set of tagging rules.

Abstract: Described herein are compositions and methods for the inhibition of miR-122 activity. The compositions have certain nucleoside modifications that yield potent inhibitors of miR-122 activity. The compounds may comprise conjugates to facilitate delivery to the liver. The compositions may be administered to subjects infected with hepatitis C virus, as a treatment for hepatitis C virus and related conditions.

Abstract: A portable USB device is described herein. The portable USB device such as a storage drive or a card reader has a built-in pass-through hub connection. Instead of clogging up the USB port availability of a computer or other host device, the device provides an extra USB female receptacle on the device to allow the computer to flow information or power charge to another USB device connected to the female receptacle.

Abstract: A system for generating web analytic reports is provided. The system includes a processor configured to receive an input web page link, execute a unified tag for the input web page link, and generate unified tagged data based on the executed unified tag. The system also includes a server side translation unit configured to translate the unified tagged data to corresponding client tagged data for each of a plurality of clients. The system further includes a plurality of client side analytical units associated with a corresponding client among the plurality of clients and communicatively coupled to the server side translation unit, wherein at least a portion of the client side analytical units are configured to analyze the corresponding client tagged data for each of the plurality of clients and generate a corresponding client side web analytics report for each of the plurality of clients.